On one hand, ACSL4 amplifies lipogenic transcriptional programs, enhances fatty acid oxidation-mediated energy adaptation, and cooperates with oncogenic signaling networks to promote tumor proliferation and survival, particularly under nutrient stress such as transarterial chemoembolization (TACE). The gene discussed is ACSL4; the disease is neoplasm.